Weltweit kleinste Herzpumpe Impella ECP erhält  „Breakthrough Device“ – Status von FDA

DANVERS, Massachusetts, USA--(BUSINESS WIRE)--The U.S. Food and Drug Administration has granted breakthrough device designation to Abiomed’s Impella ECP expandable percutaneous heart pump.